ES2158647T3 - Uso de olanzapina para la fabricacion de un medicamento para el tratamiento de la isquemia cerebral focal. - Google Patents

Uso de olanzapina para la fabricacion de un medicamento para el tratamiento de la isquemia cerebral focal.

Info

Publication number
ES2158647T3
ES2158647T3 ES98302794T ES98302794T ES2158647T3 ES 2158647 T3 ES2158647 T3 ES 2158647T3 ES 98302794 T ES98302794 T ES 98302794T ES 98302794 T ES98302794 T ES 98302794T ES 2158647 T3 ES2158647 T3 ES 2158647T3
Authority
ES
Spain
Prior art keywords
olanzapine
manufacture
treatment
cerebral ischemia
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98302794T
Other languages
English (en)
Inventor
Franklin Porter Bymaster
Gary Dennis Tollefson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2158647T3 publication Critical patent/ES2158647T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Eye Examination Apparatus (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

LA PRESENTE INVENCION DESCRIBE UN PROCEDIMIENTO PARA TRATAR LOS ACCIDENTES CEREBROVASCULARES FOCALES CEREBRALES, QUE INCLUYE ADMINISTRAR UNA DOSIFICACION TERAPEUTICAMENTE EFICAZ DE OLANZAPINA O UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE DE LA MISMA.
ES98302794T 1997-04-15 1998-04-09 Uso de olanzapina para la fabricacion de un medicamento para el tratamiento de la isquemia cerebral focal. Expired - Lifetime ES2158647T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4309597P 1997-04-15 1997-04-15

Publications (1)

Publication Number Publication Date
ES2158647T3 true ES2158647T3 (es) 2001-09-01

Family

ID=21925477

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98302794T Expired - Lifetime ES2158647T3 (es) 1997-04-15 1998-04-09 Uso de olanzapina para la fabricacion de un medicamento para el tratamiento de la isquemia cerebral focal.

Country Status (11)

Country Link
EP (1) EP0872239B1 (es)
AT (1) ATE201993T1 (es)
AU (1) AU6896198A (es)
DE (1) DE69800906T2 (es)
DK (1) DK0872239T3 (es)
ES (1) ES2158647T3 (es)
GR (1) GR3036260T3 (es)
PT (1) PT872239E (es)
SI (1) SI0872239T1 (es)
WO (1) WO1998046230A1 (es)
ZA (1) ZA982917B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1155696T3 (da) * 1997-04-15 2004-07-12 Lilly Co Eli Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse
US20020025953A1 (en) * 2000-08-17 2002-02-28 Gordon Katherine D. Novel formulations for administering therapeutic lipophilic molecules
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5605911A (en) * 1995-01-31 1997-02-25 Washington University Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5696115A (en) * 1995-04-21 1997-12-09 Eli Lilly And Company Method for treating nicotine withdrawal
US5744470A (en) * 1996-03-11 1998-04-28 Eli Lilly And Company Method for treating insomnia

Also Published As

Publication number Publication date
GR3036260T3 (en) 2001-10-31
AU6896198A (en) 1998-11-11
DE69800906T2 (de) 2001-11-15
EP0872239A3 (en) 1998-10-28
SI0872239T1 (en) 2001-10-31
PT872239E (pt) 2001-09-28
EP0872239B1 (en) 2001-06-13
DK0872239T3 (da) 2001-09-03
ATE201993T1 (de) 2001-06-15
EP0872239A2 (en) 1998-10-21
ZA982917B (en) 1999-10-06
DE69800906D1 (de) 2001-07-19
WO1998046230A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
ES2160124T3 (es) Utilizacion de bcl-2 para la fabricacion de medicamentos para el tratamiento terapeutico y la prevencion de enfermedades.
MX9304432A (es) Compuestos y formulaciones farmaceuticas para el tratamiento o prevencion de la osteoporosis y la perdida de los huesos.
PT1341533E (pt) Combinacoes sinergisticas compreendendo um inibidor de renina para doencas cardiovasculares
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ES551441A0 (es) Procedimiento para el tratamiento de formas de dosificacion farmaceuticas
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
ES2184300T3 (es) Derivados de aminoacidos utiles para tratar el accidente vascular encefalico.
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
PT656209E (pt) Derivados de melatonina para uso no tratamento de perturbacoes de dessincronizacao
ES2158647T3 (es) Uso de olanzapina para la fabricacion de un medicamento para el tratamiento de la isquemia cerebral focal.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
MX9303074A (es) Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
ES1034986Y (es) Aparato para el tratamiento del cuerpo humano.
BR9708037A (pt) Método para o tratamento de abuso de substância
FI943989L (fi) Terapeuttisia tai ehkäiseviä aineita peroksilipidiin liittyviin sairauksiin
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
ES2173550T3 (es) Uso de olanzapina para la fabricacion de un medicamento para la neuroproteccion.
MX9204485A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 872239

Country of ref document: ES